[1]
|
Goldmannova, D., Karasek, D., Krystynik, O., et al. (2016) New-Onset Diabetes Mellitus after Renal Transplantation. Biomedical Papers of the Faculty of Medicine of Palacký University, Olomouc Czech Republic, 160, 195-200.
https://doi.org/10.5507/bp.2016.005
|
[2]
|
Chen, J., Li, L., An, Y., et al. (2018) Multiple Genetic Variants Associ-ated with Posttransplantation Diabetes Mellitus in Chinese Han Populations. Journal of Clinical Laboratory Analysis, 32, e22308. https://doi.org/10.1002/jcla.22308
|
[3]
|
Dabrowska-Zamojcin, E., Romanowski, M., Dziedziejko, V., et al. (2016) CCL2 Gene Polymorphism Is Associated with Post-Transplant Diabetes Mellitus. International Immunophar-macology, 32, 62-65.
https://doi.org/10.1016/j.intimp.2016.01.011
|
[4]
|
Cen, C., Fang, H.X., Yu, S.F., et al. (2017) Association between ADIPOQ Gene Polymorphisms and the Risk of New-Onset Diabetes Mellitus after Liver Transplantation. Hepatobiliary & Pancreatic Diseases International, 16, 602-609. https://doi.org/10.1016/S1499-3872(17)60069-9
|
[5]
|
Zhang, X., Men, T., Liu, H., et al. (2018) Genetic Risk Factors for Post-Transplantation Diabetes Mellitus in Chinese Han Renal Allograft Recipients Treated with Tacrolimus. Transplant Immunology, 49, 39-42.
https://doi.org/10.1016/j.trim.2018.04.001
|
[6]
|
Wissing, K.M., Abramowicz, D., Weekers, L., et al. (2018) Pro-spective Randomized Study of Conversion from Tacrolimus to Cyclosporine A to Improve Glucose Metabolism in Pa-tients with Posttransplant Diabetes Mellitus after Renal Transplantation. American Journal of Transplantation, 18, 1726-1734. https://doi.org/10.1111/ajt.14665
|
[7]
|
Yagi, S., Kaido, T., Iida, T., et al. (2017) New-Onset Diabetes Mellitus after Living-Donor Liver Transplantation: Association with Graft Synthetic Function. Surgery Today, 47, 733-742. https://doi.org/10.1007/s00595-016-1444-z
|
[8]
|
Liang, J., Lv, C., Chen, M., et al. (2019) Effects of Pre-operative Hepatitis B Virus Infection, Hepatitis C Virus Infection, and Coinfection on the Development of New-Onset Diabetes after Kidney Transplantation. Journal of Diabetes, 11, 370-378. https://doi.org/10.1111/1753-0407.12853
|
[9]
|
Huang, J.W., Famure, O., Li, Y., et al. (2016) Hypomagnesemia and the Risk of New-Onset Diabetes Mellitus after Kidney Transplantation. Journal of the American Society of Nephrol-ogy, 27, 1793-1800.
https://doi.org/10.1681/ASN.2015040391
|
[10]
|
Garg, N., Weinberg, J., Ghai, S., et al. (2014) Lower Magnesium Level Associated with New-Onset Diabetes and Pre-Diabetes after Kidney Transplantation. Journal of Nephrology, 27, 339-344.
https://doi.org/10.1007/s40620-014-0072-1
|
[11]
|
Yu, H., Kim, H., Baek, C.H., et al. (2016) Risk Factors for New-Onset Diabetes Mellitus after Living Donor Kidney Transplantation in Korea—A Retrospective Single Center Study. BMC Nephrology, 17, Article No. 106.
https://doi.org/10.1186/s12882-016-0321-8
|
[12]
|
Le Fur, A., Fournier, M.C., Gillaizeau, F., et al. (2016) Vitamin D Deficiency Is an Independent Risk Factor for PTDM after Kidney Transplantation. Transplant International, 29, 207-215. https://doi.org/10.1111/tri.12697
|
[13]
|
Dedinska, I., Laca, L., Miklusica, J., et al. (2018) The Role of Pro-teinuria, Paricalcitol and Vitamin D in the Development of Post-Transplant Diabetes Mellitus. Bratislava Medical Jour-nal, 119, 401-407.
https://doi.org/10.4149/BLL_2018_073
|
[14]
|
Xue, M., Zhao, C., Lv, C., et al. (2018) Interleukin-2 Receptor An-tagonists: Protective Factors against New-Onset Diabetes after Renal Transplantation. Journal of Diabetes, 10, 857-865. https://doi.org/10.1111/1753-0407.12663
|
[15]
|
何顺梅, 张尧, 陈显英, 等. 白细胞介素2受体拮抗剂对器官移植受体糖代谢的影响[J]. 中华内分泌代谢杂志, 2013, 29(6): 540-543.
|
[16]
|
Sharif, A. and Baboolal, K. (2011) Com-plications Associated with New-Onset Diabetes after Kidney Transplantation. Nature Reviews Nephrology, 8, 34-42. https://doi.org/10.1038/nrneph.2011.174
|
[17]
|
Nadav, M., Marius, B., Tuvia, B.G., et al. (2020) Post-Transplant Diabetes Mellitus: Incidence, Predicting Factors and Outcomes. Endocrine, 69, 303-309. https://doi.org/10.1007/s12020-020-02339-9
|
[18]
|
Borda, B., Lazar, G., Kormanyos, A., et al. (2019) New-Onset Diabetes Mellitus Following Successful Kidney Transplantation Facilitates Aortic Stiffening. Transplantation Proceed-ings, 51, 1239-1243.
https://doi.org/10.1016/j.transproceed.2019.04.009
|
[19]
|
Xu, Y., Liang, J.X., Liu, B., et al. (2011) Prevalence and Long-Term Glucose Metabolism Evolution of Post-Transplant Diabetes Mellitus in Chinese Renal Recipients. Diabetes Research and Clinical Practice, 92, 11-18.
https://doi.org/10.1016/j.diabres.2010.12.006
|
[20]
|
American Diabetes Association (2012) Diagnosis and Classifi-cation of Diabetes Mellitus. Diabetes Care, 35, 64-71.
https://doi.org/10.2337/dc12-s064
|
[21]
|
Londero, T.M., Giaretta, L.S., Farenzena, L.P., et al. (2019) Microvascular Complications of Posttransplant Diabetes Mellitus in Kidney Transplant Recipients: A Longitudinal Study. The Journal of Clinical Endocrinology and Metabolism, 104, 557-567. https://doi.org/10.1210/jc.2018-01521
|
[22]
|
Fiorina, P., Lv, C., Chen, M., et al. (2014) Influencing Factors of New-Onset Diabetes after a Renal Transplant and Their Effects on Complications and Survival Rate. PLOS ONE, 9, e99406.
https://doi.org/10.1371/journal.pone.0099406
|
[23]
|
Siraj, E.S., Abacan, C., Chinnappa, P., et al. (2010) Risk Fac-tors and Outcomes Associated with Posttransplant Diabetes Mellitus in Kidney Transplant Recipients. Transplantation Proceedings, 42, 1685-1689.
https://doi.org/10.1016/j.transproceed.2009.12.062
|
[24]
|
Thangavelu, T., Lyden, E. and Shivaswamy, V. (2020) A Retrospective Study of Glucagon-Like Peptide 1 Receptor Agonists for the Management of Diabetes after Transplanta-tion. Diabetes Therapy, 11, 987-994.
https://doi.org/10.1007/s13300-020-00786-1
|
[25]
|
Singh, P., Pesavento, T.E., Washburn, K., et al. (2018) Largest Single-Centre Experience of Dulaglutide for Management of Diabetes Mellitus in Solid Organ Transplant Recipients. Diabetes, Obesity and Metabolism, 21, 1061-1065.
https://doi.org/10.1111/dom.13619
|
[26]
|
Joo, K.W., Kim, S., Ahn, S.Y., et al. (2013) Dipeptidyl Peptidase IV In-hibitor Attenuates Kidney Injury in Rat Remnant Kidney. BMC Nephrology, 14, Article No. 98. https://doi.org/10.1186/1471-2369-14-98
|
[27]
|
Mahling, M., Schork, A., Nadalin, S., et al. (2019) Sodium-Glucose Cotransporter 2 (SGLT2) Inhibition in Kidney Transplant Recipients with Diabetes Mellitus. Kidney & Blood Pressure Research, 44, 984-992.
https://doi.org/10.1159/000501854
|
[28]
|
Galindo, R.J., Fried, M., Breen, T., et al. (2016) Hyperglycemia Manage-ment in Patients with Posttransplantation Diabetes. Endocrine Practice, 22, 454-465. https://doi.org/10.4158/EP151039.RA
|
[29]
|
Hecking, M., Haidinger, M., Doller, D., et al. (2012) Early Basal Insu-lin Therapy Decreases New-Onset Diabetes after Renal Transplantation. Journal of the American Society of Nephrology, 23, 739-749.
https://doi.org/10.1681/ASN.2011080835
|